Stock Pick

The Latest

  • Here’s Why We’re Not Too Worried About Intra-Cellular Therapies’ (NASDAQ:ITCI) Cash Burn Situation

    ·

  • Goldman Sachs boosts gold price target, says the U.S. dollar’s reserve status is at risk

    ·

  • Argonaut Gold Drills High-Grade Intercept of 6.0 Metres at 8.31 g/t at Magino; Phase Two Magino Drill Program Shows Promising Continuity Between High-Grade Intercepts in the Elbow Zone, including 20.0 Metres at 4.58 g/t Gold

    ·

  • Pfizer’s October Goal in Vaccine Race Scrutinized by Street

    ·